This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The State University of New York, Brook Biotechnologies, Inc., Brook Biotechnology, Inc.. Active years: 2006-2009.
Company Filing History:
2 out of 2,043 
1 out of 1 
1 out of 1 Years Active: 2006-2009
Title: The Innovations of Daniel Dykhuizen
Introduction
Daniel Dykhuizen is an accomplished inventor based in St. James, NY (US). He has made significant contributions to the field of immunology, particularly in the development of compositions related to Lyme Disease. With a total of 2 patents, Dykhuizen's work showcases his dedication to advancing medical science.
Latest Patents
Dykhuizen's latest patents focus on immunogenic compositions comprising OspC polypeptides from Lyme Disease-causing agents. In one embodiment, the immunogenic composition includes at least one OspC polypeptide or immunogenic fragment from each of OspC families A, B, I, and K. Another embodiment emphasizes the inclusion of OspC polypeptides or immunogenic fragments from OspC families A and B. These innovations are crucial in the ongoing fight against Lyme Disease.
Career Highlights
Throughout his career, Dykhuizen has worked with notable institutions such as the State University of New York and Brook Biotechnologies, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Dykhuizen has collaborated with esteemed colleagues, including Gerald Seinost and Benjamin J. Luft. These partnerships have further enriched his research and development efforts in immunology.
Conclusion
Daniel Dykhuizen's contributions to the field of immunology through his patents and collaborations highlight his commitment to innovation and improving public health. His work continues to inspire advancements in the fight against Lyme Disease.